Toll-like receptor (TLR) expression and TLR‑mediated interleukin-8 production by human submandibular gland epithelial cells

Ohta,Kouji; Ishida,Yoko; Fukui,Akiko; Mizuta,Kuniko; Nishi,Hiromi; Takechi,Masaaki; Kamata,Nobuyuki

doi:10.3892/mmr.2014.2507

Toll-like receptor (TLR) expression and TLR‑mediated interleukin-8 production by human submandibular gland epithelial cells

Authors:
- Kouji Ohta
- Yoko Ishida
- Akiko Fukui
- Kuniko Mizuta
- Hiromi Nishi
- Masaaki Takechi
- Nobuyuki Kamata
View Affiliations

Affiliations: Department of Oral and Maxillofacial Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan
Published online on: August 21, 2014 https://doi.org/10.3892/mmr.2014.2507
Pages: 2377-2382

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Toll-like receptor (TLR) family members are pattern recognition receptors that are essential in the activation of innate and adaptive immune responses. Submandibular gland epithelial cells (SMGCs) may recognize microbial components through TLRs and be involved in the development of inflammatory reactions in the submandibular glands. Therefore, the functional expression of TLRs in SMGCs was investigated in the present study. The mRNA expression of TLRs in SMGC and whole submandibular tissues was determined by RT-PCR. Subsequently, the effects of various TLR agonists and tumor necrosis factor alpha (TNF-α) on IL-8 production were examined using an ELISA. SMGCs, as well as whole submandibular tissues, expressed TLR1-10 mRNA. Furthermore, interleukin (IL)-8 production in SMGCs was increased by Pam3CSK4 (TLR1/2 agonist), poly I:C (TLR3 agonist), E. coli lipopolysaccharide (LPS; TLR4 agonist), flagellin (TLR5 agonist) and macrophage‑activating lipopeptide (MALP)-2 (TLR2/6 agonist) treatments in a dose‑dependent manner, whereas administration of either imiquimod (TLR7 agonist) or CpG-oligodeoxynucletide (TLR9 agonist) exerted no evident effect. Pam3CSK4, poly I:C, LPS, flagellin and MALP-2 also enhanced TNF‑α‑induced IL-8 production in SMGCs. These findings suggest that innate immune responses against microbial components result in the development of TNF-α-mediated autoimmune inflammatory disease in the submandibular glands.

View Figures

View References

1	Takeda K, Kaisho T and Akira S: Toll-like receptors. Annu Rev Immunol. 21:335–376. 2003. View Article : Google Scholar
2	Midwood KS, Piccinini AM and Sacre S: Targeting Toll-like receptors in autoimmunity. Curr Drug Targets. 10:1139–1155. 2009. View Article : Google Scholar : PubMed/NCBI
3	Kumar H, Kawai T and Akira S: Toll-like receptors and innate immunity. Biochem Biophys Res Commun. 388:621–625. 2009. View Article : Google Scholar : PubMed/NCBI
4	Han DC, Huang GT, Lin LM, et al: Expression of MHC Class II, CD70, CD80, CD86 and pro-inflammatory cytokines is differentially regulated in oral epithelial cells following bacterial challenge. Oral Microbiol Immunol. 18:350–358. 2003. View Article : Google Scholar
5	Kawai T, Takeuchi O, Fujita T, et al: Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol. 167:5887–5894. 2001. View Article : Google Scholar
6	Anders HJ, Vielhauer V, Eis V, et al: Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas (lpr) mice. FASEB J. 18:534–536. 2004.PubMed/NCBI
7	Kobayashi Y, Murakami H, Akbar SM, Matsui H and Onji M: A novel and effective approach of developing aggressive experimental autoimmune gastritis in neonatal thymectomized BALB/c mouse by polyinosinic:polycytidylic acid. Clin Exp Immunol. 136:423–431. 2004. View Article : Google Scholar
8	Qu WM, Miyazaki T, Terada M, et al: A novel autoimmune pancreatitis model in MRL mice treated with polyinosinic:polycytidylic acid. Clin Exp Immunol. 129:27–34. 2002. View Article : Google Scholar : PubMed/NCBI
9	Birchler T, Seibl R, Büchner K, et al: Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human beta-defensin 2 in response to bacterial lipoprotein. Eur J Immunol. 31:3131–3137. 2001. View Article : Google Scholar : PubMed/NCBI
10	Böcker U, Yezerskyy O, Feick P, et al: Responsiveness of intestinal epithelial cell lines to lipopolysaccharide is correlated with Toll-like receptor 4 but not Toll-like receptor 2 or CD14 expression. Int J Colorectal Dis. 18:25–32. 2003.
11	Hertz CJ, Wu Q, Porter EM, et al: Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2. J Immunol. 171:6820–6826. 2003. View Article : Google Scholar : PubMed/NCBI
12	Spachidou MP, Bourazopoulou E, Maratheftis CI, et al: Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjögren’s syndrome. Clin Exp Immunol. 147:497–503. 2007.PubMed/NCBI
13	Shimizu S, Kurashige Y, Nishimura M, et al: Involvement of toll-like receptors in autoimmune sialoadenitis of the non-obese diabetic mouse. J Oral Pathol Med. 41:517–523. 2012.PubMed/NCBI
14	Roescher N, Tak PP and Illei GG: Cytokines in Sjögren’s syndrome. Oral Dis. 15:519–526. 2009.
15	Fox RI, Kang HI, Ando D, Abrams J and Pisa E: Cytokine mRNA expression in salivary gland biopsies of Sjögren’s syndrome. J Immunol. 152:5532–5539. 1994.
16	Cuello C, Palladinetti P, Tedla N, et al: Chemokine expression and leucocyte infiltration in Sjögren’s syndrome. Br J Rheumatol. 37:779–783. 1998.
17	Pflugfelder SC, Jones D, Ji Z, Afonso A and Monroy D: Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren’s syndrome keratoconjunctivitis sicca. Curr Eye Res. 19:201–211. 1999.PubMed/NCBI
18	Ohta K, Shigeishi H, Taki M, et al: Regulation of CXCL9/10/11 in human oral keratinocytes and fibroblasts. J Dent Res. 87:1160–1165. 2008. View Article : Google Scholar
19	Dimitriou ID, Kapsogeorgou EK, Abu-Helu RF, Moutsopoulos HM and Manoussakis MN: Establishment of a convenient system for the long-term culture and study of non-neoplastic human salivary gland epithelial cells. Eur J Oral Sci. 110:21–30. 2002. View Article : Google Scholar
20	Szlávik V, Szabó B, Vicsek T, et al: Differentiation of primary human submandibular gland cells cultured on basement membrane extract. Tissue Eng Part A. 14:1915–1926. 2008.PubMed/NCBI
21	Nishimura M and Naito S: Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. Biol Pharm Bull. 28:886–892. 2005. View Article : Google Scholar : PubMed/NCBI
22	Zarember KA and Godowski PJ: Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol. 168:554–561. 2002. View Article : Google Scholar : PubMed/NCBI
23	Park JH, Yoon HE, Kim DJ, et al: Toll-like receptor 5 activation promotes migration and invasion of salivary gland adenocarcinoma. J Oral Pathol Med. 40:187–193. 2011. View Article : Google Scholar : PubMed/NCBI
24	Ittah M, Miceli-Richard C, Gottenberg JE, et al: Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways. Eur J Immunol. 38:1058–1064. 2008. View Article : Google Scholar : PubMed/NCBI
25	Zheng L, Zhang Z, Yu C and Yang C: Expression of Toll-like receptors 7, 8, and 9 in primary Sjögren’s syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 109:844–850. 2010.PubMed/NCBI
26	Kawakami A, Nakashima K, Tamai M, et al: Toll-like receptor in salivary glands from patients with Sjögren’s syndrome: functional analysis by human salivary gland cell line. J Rheumatol. 34:1019–1026. 2007.
27	Deshmukh US, Nandula SR, Thimmalapura PR, Scindia YM and Bagavant H: Activation of innate immune responses through Toll-like receptor 3 causes a rapid loss of salivary gland function. J Oral Pathol Med. 38:42–47. 2009. View Article : Google Scholar
28	Matsumura R, Umemiya K, Goto T, et al: Interferon gamma and tumor necrosis factor alpha induce Fas expression and anti-Fas mediated apoptosis in a salivary ductal cell line. Clin Exp Rheumatol. 18:311–318. 2000.PubMed/NCBI
29	Hajnická V, Kocáková P, Sláviková M, et al: Anti-interleukin-8 activity of tick salivary gland extracts. Parasite Immunol. 23:483–489. 2001.PubMed/NCBI
30	Akira S and Takeda K: Toll-like receptor signalling. Nat Rev Immunol. 4:499–511. 2004. View Article : Google Scholar
31	Ittah M, Miceli-Richard C, Gottenberg JE, et al: B-cell-activating factor expressions in salivary epithelial cells after dsRNA virus infection depends on RNA-activated protein kinase activation. Eur J Immunol. 39:1271–1279. 2009. View Article : Google Scholar
32	Lisi S, Sisto M, Lofrumento DD and D’Amore M: Sjögren’s syndrome autoantibodies provoke changes in gene expression profiles of inflammatory cytokines triggering a pathway involving TACE/NF-κB. Lab Invest. 92:615–624. 2012.
33	Li J, Kartha S, Iasvovskaia S, et al: Regulation of human airway epithelial cell IL-8 expression by MAP kinases. Am J Physiol Lung Cell Mol Physiol. 283:L690–L699. 2002.PubMed/NCBI